SynthesisFrontiers in immunology2025

Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherapy: a meta-analysis.

Weiming Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.